COVID-19 vaccine: UK regulator identifies 30 blood clots after AstraZeneca shot use

British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.

The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc.

Also read: EU medicine regulator says no blood clot risks attached to AstraZeneca COVID-19 vaccine

Also read: COVID-19 vaccine: Germany to restrict AstraZeneca in people over 60 years due to blood clot reports